Piramal Pharma Clarifies Share Price Surge, Cites Market Dynamics

Piramal Pharma Ltd has responded to a stock exchange query regarding a news article that reported a significant surge in its share price. The company clarified that the referenced article does not contain any new material information requiring disclosure under SEBI regulations. Piramal Pharma stated that all previously disclosed information is in the public domain and there are no undisclosed material events. The company attributes the recent share price movement to market dynamics and is not aware of any specific reason for the observed rally.